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Dear Editors,
We have read the comments of Dr. Vieth with interest. We
agree that the dosing interval does not need to be much
shorter than the circulating half-life of 25(OH)D, anywhere
between 10 days and 2 months, according to different
assessments [1, 2].
The difference between the daily and weekly dose with
regard to serum 25(OH)D was significant but not clinically
relevant. However, the difference between these doses and
the monthly dose is clinically relevant with regard to serum
25(OH)D and serum PTH. In any case, the mechanism of
the effect of an increase of serum 25(OH)D on serum PTH
is a complex question, and different effects according to
different dosing intervals cannot be ruled out.
The compliance in our study was high as the nurses
distributed the medication and supervised the ingestion.
Our study was not a rigorous pharmacological study;
however, it simply demonstrates that results of vitamin D
supplementationdonotsolelydependonthecumulativedose.
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